Objective. To determine the frequency of infection by Helicobacter pylori (HP) and premalignant gastric lesions (PGL) in patients with non-studied dyspepsia, in a general hospitalin Lima. Material and methods. It was carried out a descriptive, cross-sectional, retrospective study. The study population corresponded to outpatients referred to the Hospital EsSalud Uldarico Rocca Fernandez, Villa El Salvador, Lima, with a diagnosis of non-studied dyspepsia, who underwent upper gastrointestinal endoscopy between April 2012 and March 2014. Clinical and anatomopathological characteristics were evaluated. Results. 2 790 patients were studied, average age 48,6 (SD ± 15,3) year-old, range: 14-91 year-old. We found a global frequency of HP infection in 61,3 % (95%CI: 59,5-63,1) and premalignant gastric lesions in 23,6 % (95%CI: 22-25,1). A statistically significant association was found between pa...

 Objective: To determine if the eradication rate of Helicobacter pylori with first line triple therapy for 14 days is better than with 10 days. Material and methods: Retrospective cohort study. It was reviewed medical records of the patients with dyspepsia and upper digestive endoscopy with a positive H. pylori biopsy, who received triple therapy with amoxicillin, clarithromycin and omeprazole for 10 or 14 days. Eradication was defined by the 13C-UBT breath test, 4 to 6 weeks after treatment. Results: It was evaluated 381 patients, 207 received treatment for 10 days and 174 for 14 days. The average age was 49 ± 13.9(15 to 82) years. The female sex was predominating (69,8%). The eradication rate of H. pylori in the 10-day and 14-day treatment group was 79, 7% and 82, 2% respectively (risk ratio, 1.03; 95% confidence interval, 0.94-1.14; p=0,541). Adverse events were reported in 75,1...

 Objective: To determine if the eradication rate of Helicobacter pylori with first line triple therapy for 14 days is better than with 10 days. Material and methods: Retrospective cohort study. It was reviewed medical records of the patients with dyspepsia and upper digestive endoscopy with a positive H. pylori biopsy, who received triple therapy with amoxicillin, clarithromycin and omeprazole for 10 or 14 days. Eradication was defined by the 13C-UBT breath test, 4 to 6 weeks after treatment. Results: It was evaluated 381 patients, 207 received treatment for 10 days and 174 for 14 days. The average age was 49 ± 13.9(15 to 82) years. The female sex was predominating (69,8%). The eradication rate of H. pylori in the 10-day and 14-day treatment group was 79, 7% and 82, 2% respectively (risk ratio, 1.03; 95% confidence interval, 0.94-1.14; p=0,541). Adverse events were reported in 75,1...

Objective. To determine the frequency of infection by Helicobacter pylori (HP) and premalignant gastric lesions (PGL) in patients with non-studied dyspepsia, in a general hospitalin Lima. Material and methods. It was carried out a descriptive, cross-sectional, retrospective study. The study population corresponded to outpatients referred to the Hospital EsSalud Uldarico Rocca Fernandez, Villa El Salvador, Lima, with a diagnosis of non-studied dyspepsia, who underwent upper gastrointestinal endoscopy between April 2012 and March 2014. Clinical and anatomopathological characteristics were evaluated. Results. 2 790 patients were studied, average age 48,6 (SD ± 15,3) year-old, range: 14-91 year-old. We found a global frequency of HP infection in 61,3 % (95%CI: 59,5-63,1) and premalignant gastric lesions in 23,6 % (95%CI: 22-25,1). A statistically significant association was found between pa...

Objetivo: Determinar si la tasa de erradicación de Helicobacter pylori con terapia triple de primera línea durante 14 días es superior que con 10 días. Material y Métodos: Estudio de cohortes retrospectivo. Se revisaron las historias clínicas de pacientes con dispepsia y endoscopia digestiva alta con biopsia positiva a H. pylori, quienes recibieron terapia triple con amoxicilina, claritromicina y omeprazol durante 10 ó 14 días. La erradicación se definió con la prueba del aliento 13C-UBT, 4 a 6 semanas post tratamiento. Resultados: Se estudiaron 381 pacientes, 165 recibieron tratamiento por 10 días y 174 por 14 días. La edad promedio fue 49 (DE ± 13,9) años, rango de 15 a 82 años. Predominó el sexo femenino (69,8%). La tasa de erradicación de H. pylori en el grupo de tratamiento de 10 días y 14 días fue 79,7% y 82,2% respectivamente. RR: 1,03 (IC 95%: 0,94 – 1,14) (p...

OBJETIVO: Identificar la correlación entre el resultado del uso de los criterios modificados de la ATS (American Thoracic Society) y la mortalidad por NAC severa en pacientes adultos hospitalizados en el HNDAC. MATERIAL Y METODOS: El presente es un estudio de tipo observacional analítico retrospectivo, el cual se realizó a partir de las historias clínicas de los pacientes adultos hospitalizados en los Servicios de Medicina, Neumología y de Cuidados críticos del Hospital Nacional Daniel A. Carrión, con el diagnóstico de Neumonía, durante el año 2003. Los pacientes con diagnóstico de Neumonía fueron divididos en 2 grupos, Neumonía severa y Neumonía no severa. Para seleccionar a los pacientes con diagnóstico de neumonía severa, se utilizaron los criterios modificados de la ATS. RESULTADOS: Se estudiaron 115 pacientes, los cuales fueron divididos en 2 grupos, aplicando los Cr...